RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc.
RTW Biotech Opportunities Ltd (LSE:RTW) a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc on February 13, 2024. Under the terms of the Scheme, RTW Bio has now issued 181,901,165 new ordinary shares of no par value in the capital of RTW Bio (the "New RTW Bio Shares") to the Liquidators, who have renounced them in favour of eligible Arix shareholders, to satisfy the consideration due under the terms of the Scheme.